research communications
Structural characterization of borneol dehydrogenase from Pseudomonas sp. TCU-HL1
aDepartment of Biochemistry, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan, bInstitute of Medical Sciences, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan, cDepartment of Biochemistry, University of Medicine 1, Yangon, Myanmar, dIntegration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan, and eInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan
*Correspondence e-mail: huangkf@gate.sinica.edu.tw, kotping@gate.sinica.edu.tw
During the microbial degradation of borneol, a bicyclic plant monoterpene, it is first converted into camphor by borneol dehydrogenase (BDH) and then enters a known camphor-degradation pathway. Previously, a recombinant Pseudomonas BDH was found in inclusion bodies when expressed in Escherichia coli. After refolding, it was still unstable and was difficult to concentrate. Here, the protein-expression conditions were improved by changing the medium from lysogeny broth to Terrific Broth, yielding a soluble form of the enzyme with higher activity. The protein was crystallized and its 3D structure was determined by X-ray diffraction. Like other known homologues such as quinuclidinone reductase, the protein forms a tetramer with subunits containing Rossmann folds. Structural comparison revealed major differences in the C-terminal helices and the associated loops. It is likely that these regions contain the determinants for substrate recognition.
Keywords: plant terpenoids; camphor; oxidoreductases; Rossmann fold; NAD; expression medium; protein solubility.
PDB reference: borneol dehydrogenase, 6m5n
1. Introduction
Borneol is one of the terpenoid et al., 2002). Borneol has commonly been used in traditional Chinese medicine for many years. It can relieve pain and serve as an analgesic and anesthetic agent (Hattori, 2000). Pharmacological effects such as anti-inflammation, neuroprotection and blood–brain barrier penetration have been reported (Liu et al., 2011; Zhong et al., 2014; Yin et al., 2017).
that are naturally synthesized in plants and exists in two enantiomeric forms: (+)-borneol and (−)-borneol. (+)-Borneol is also a precursor in the biosynthetic pathway of natural (+)-camphor (JuteauThe degradation of borneol in microorganisms has previously been reported by our group (Tsang et al., 2016). Borneol dehydrogenase (BDH; accession No. WP_069084981) converts borneol into camphor in Pseudomonas sp. TCU-HL1 (Fig. 1). The camphor is then metabolized by this microorganism through a known camphor-degradation pathway (Ougham et al., 1983; Taylor & Trudgill, 1986; Leisch et al., 2012; Iwaki et al., 2013). The gene encoding this enzyme, bdh, with locus tag TCL1_4180, was found in the camphor-degradation gene cluster. Recombinant BDH was produced in the form of inclusion bodies in Escherichia coli BL21(DE3) cells. However, even after refolding, it was unstable and very easily precipitated. Consequently, various protein-induction methods have been tested in order to improve the solubility of this recombinant enzyme.
The BDH protein is homologous in primary sequence to a number of other Agrobacterium tumefaciens (AtQR; 36.4% identity; PDB entries 3ak4 and 3wds; Hou et al., 2014). The enzyme assembles into a tetramer of four identical subunits; each subunit contains a central parallel β-sheet with flanking α-helices. Here, to provide a structural basis for future design and engineering to modify the substrate specificity of BDH, we crystallized the protein and determined its 3D structure.
for which three-dimensional structures are available in the Protein Data Bank. The most similar is the 3-quinuclidinone reductase from2. Materials and methods
2.1. Macromolecule production
The expression vector pbdhX, derived from pET-30 (Tsang et al., 2016), was used to transform E. coli BL21(DE3) cells for recombinant BDH production. The bacterial growth and induction conditions were the same as reported previously, except that Terrific Broth (TB) was used instead of lysogeny broth (LB). All purification steps were carried out at 4°C. About 10 g of cells (wet weight) were resuspended in 50 ml 10 mM sodium phosphate buffer pH 7.0, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol (DTT) and were ruptured by sonication. The crude extracts were clarified by centrifugation at 25 000g for 15 min. The supernatant was brought to 20% ammonium sulfate saturation, clarified by centrifugation and loaded onto a Phenyl Sepharose High Performance column (2.6 × 70 cm) pre-equilibrated with 400 ml buffer A (1 M ammonium sulfate, 10 mM sodium phosphate pH 7). The proteins were eluted with buffer A from 0 to 50 ml, with 100% buffer A to 100% buffer B (10 mM sodium phosphate pH 7) from 50 to 1050 ml and with buffer B from 1050 to 1250 ml. The BDH activity was determined using the procedure reported previously (Tsang et al., 2016), and fractions containing BDH activity were pooled. After overnight dialysis against buffer B with 1 mM DTT, the protein solution was loaded onto a Q Sepharose Fast Flow anion-exchange column (2.6 × 50 cm) and eluted using the method described above, in which buffer A was replaced by buffer B and the second buffer was buffer B with 0.5 M KCl. Macromolecule-production information is summarized in Table 1.
‡The BamHI site is underlined. |
2.2. Crystallization
For crystallization experiments, the purified BDH was dialyzed and concentrated to ∼10 mg ml−1 in a new buffer consisting of 50 mM Tris–HCl pH 8.0, 5% glycerol. An initial crystallization screening of ∼800 conditions was performed at the Protein Crystallization Facility, Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan. Single crystals were found in PEG-containing drops. After optimization, diffraction-quality crystals were obtained using a reservoir solution consisting of 30%(w/v) PEG 8000, 0.1 M sodium acetate pH 4.5, 0.2 M lithium sulfate. The crystals were grown at 20°C by the sitting-drop vapor-diffusion method. Crystallization information is summarized in Table 2.
|
2.3. Data collection and processing
The crystals were first analyzed using the in-house X-ray facility at the Institute of Biological Chemistry, Academia Sinica. They belonged to the orthorhombic F222, with one BDH molecule in the High-resolution X-ray diffraction data collection was carried out on the Taiwan Light Source (TLS) beamline BL15A1 at the National Synchrotron Radiation Research Center (NSRRC), Hsinchu, Taiwan. Prior to flash-cooling for data collection, the BDH crystals were soaked briefly in reservoir solution containing 10–15%(v/v) glycerol as a cryoprotectant. In an attempt to obtain complex crystals, 5 mM NAD was added to the reservoir solution. The diffraction intensities were integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997). Data-collection and processing statistics are summarized in Table 3.
|
2.4. Structure solution and refinement
The MOLREP (Vagin & Teplyakov, 2010) from CCP4 (Winn et al., 2011) with PDB entry 3ak4 as a search model and was refined to 1.84 Å resolution using Phenix (Liebschner et al., 2019) and Coot (Emsley et al., 2010). Use of translation–libration–screw (TLS) parameters did not improve the R values, and therefore all atoms were treated with isotropic temperature factors. MolProbity (Chen et al., 2010) was used for Ramachandran analysis. In addition to the NAD from PDB entry 3ak4, a model of camphor (CAM) was generated and both were placed into the active site of BDH using Phenix and Coot. Among the top 100 BDH-like structures in the PDB found by the DALI server (Holm, 2019), only a few contained bound substrates. These served as a guide for positioning the CAM model, which was subsequently improved by repeated manual adjustment and regularization according to the known structures and stereochemical restraints. In particular, the carbonyl group of CAM was oriented for the correct handedness of borneol upon hydride transfer. All figures showing 3D protein structures were produced using PyMOL (https://pymol.org/). are summarized in Table 4.
was solved using
|
3. Results and discussion
3.1. Expression of soluble BDH
Most of the recombinant BDH was produced in a soluble form in crude extracts of E. coli using Terrific Broth as the growth medium. This was in contrast to the previous results using LB medium, in which the recombinant BDH was found in inclusion bodies and required refolding to solubilize it (Tsang et al., 2016). The of the soluble form of BDH turned out to be about 40-fold higher than that of the refolded enzyme. A homogeneous preparation of the enzyme was obtained after purification steps using hydrophobic and anion-exchange columns (Supplementary Fig. S1). The purified BDH was very stable and did not precipitate upon subsequent dialysis and concentration.
3.2. of BDH
The refined model of the orthorhombic BDH crystal contains an unbroken polypeptide chain from the N-terminal Lys2 to the C-terminal Arg260. As shown in Fig. 2(a), the protein features a seven-stranded antiparallel β-sheet flanked by three α-helices on each side, making up a Rossmann-fold structure. The longer helices α4 and α5 on one side protrude over the C-terminal ridge of the β-sheet, where the cofactor NAD is supposed to bind. On the other side, two additional helices α6′′ and α6′ are inserted between strand βF and helix α6. The space surrounded by these four α-helices should participate in substrate binding and catalysis. However, soaking experiments failed to show electron density for NAD.
Although the F222 crystal only contains one BDH protomer in the a similar tetramer to those of AtQR and other homologous can be generated by operations, as shown in Fig. 2(b). The protein–protein interface buries 3520 Å2 (28%) of the total 12 520 Å2 surface area of each protomer. The tetramers of BDH and AtQR (PDB entry 3ak4) superimpose well, with an overall root-mean-square deviation (r.m.s.d.) of 1.69 Å for 964 pairs of matched Cα atoms (Supplementary Fig. S2). If individual protomers are compared, the r.m.s.d. ranges from 1.52 to 1.58 Å for 239–242 Cα pairs. The regions that differ the most are located in helices α6′′, α6′ and α6 and the associated loops, as shown in Fig. 2(c).
3.3. Substrate-binding mode
The nicotinamide moiety of NAD from AtQR lies at the bottom of a cavity in BDH, surrounded by loop βD–α4, loop βE–α5, loop βF–α6′′ and helix α6′′ (Supplementary Fig. S3). While the NAD-binding site is largely conserved, the surrounding regions are variable, which should account for the binding to the preferred substrate. In this regard, three substrate-containing structures, PDB entries 1e6w (Powell et ;al., 2000), 3o03 (Zhang et al., 2009) and 6ihh (Chen et al., 2019), were compared and a BDH substrate was modeled into the active site (Fig. 3). The plausible binding mode suggests hydrogen bonding between the His96 and Tyr157 side chains and the borneol hydroxy group, as well as nonpolar contacts of the Phe233 side chain with the dimethyl group. However, the precise enzyme–substrate interactions have yet to be revealed by further investigations.
Supporting information
PDB reference: borneol dehydrogenase, 6m5n
Supplementary Figures. DOI: https://doi.org/10.1107/S2053230X20008584/no5178sup1.pdf
Acknowledgements
The authors are grateful to NSRRC for allocation of beam time and assistance with data collection.
Funding information
This work was supported by Tzu Chi University (grant No. TCMRC-P-108006) and the Academia Sinica (grant Nos. AS-KPQ-109-TPP2 and AS-KPQ-109-ITAR-11).
References
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. Web of Science CrossRef CAS IUCr Journals Google Scholar
Chen, X., Zhang, H., Maria-Solano, M. A., Liu, W., Li, J., Feng, J., Liu, X., Osuna, S., Guo, R.-T., Wu, Q., Zhu, D. & Ma, Y. (2019). Nat. Catal. 2, 931–941. CrossRef CAS Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Hattori, A. (2000). Yakushigaku Zasshi, 35, 49–54. PubMed CAS Google Scholar
Holm, L. (2019). Bioinformatics, 35, 5326–5327. Web of Science CrossRef PubMed Google Scholar
Hou, F., Miyakawa, T., Kataoka, M., Takeshita, D., Kumashiro, S., Uzura, A., Urano, N., Nagata, K., Shimizu, S. & Tanokura, M. (2014). Biochem. Biophys. Res. Commun. 446, 911–915. CrossRef CAS PubMed Google Scholar
Iwaki, H., Grosse, S., Bergeron, H., Leisch, H., Morley, K., Hasegawa, Y. & Lau, P. C. K. (2013). Appl. Environ. Microbiol. 79, 3282–3293. Web of Science CrossRef CAS PubMed Google Scholar
Juteau, F., Masotti, V., Bessière, J. M., Dherbomez, M. & Viano, J. (2002). Fitoterapia, 73, 532–535. CrossRef PubMed CAS Google Scholar
Leisch, H., Shi, R., Grosse, S., Morley, K., Bergeron, H., Cygler, M., Iwaki, H., Hasegawa, Y. & Lau, P. C. K. (2012). Appl. Environ. Microbiol. 78, 2200–2212. CrossRef CAS PubMed Google Scholar
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., Moriarty, N. W., Oeffner, R. D., Poon, B. K., Prisant, M. G., Read, R. J., Richardson, J. S., Richardson, D. C., Sammito, M. D., Sobolev, O. V., Stockwell, D. H., Terwilliger, T. C., Urzhumtsev, A. G., Videau, L. L., Williams, C. J. & Adams, P. D. (2019). Acta Cryst. D75, 861–877. Web of Science CrossRef IUCr Journals Google Scholar
Liu, R., Zhang, L., Lan, X., Li, L., Zhang, T.-T., Sun, J.-H. & Du, G.-H. (2011). Neuroscience, 176, 408–419. CrossRef CAS PubMed Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. CrossRef CAS PubMed Web of Science Google Scholar
Ougham, H. J., Taylor, D. G. & Trudgill, P. W. (1983). J. Bacteriol. 153, 140–152. CrossRef CAS PubMed Google Scholar
Powell, A. J., Read, J. A., Banfield, M. J., Gunn-Moore, F., Yan, S. D., Lustbader, J., Stern, A. R., Stern, D. M. & Brady, R. L. (2000). J. Mol. Biol. 303, 311–327. Web of Science CrossRef PubMed CAS Google Scholar
Taylor, D. G. & Trudgill, P. W. (1986). J. Bacteriol. 165, 489–497. CrossRef CAS PubMed Google Scholar
Tsang, H.-L., Huang, J.-L., Lin, Y.-H., Huang, K.-F., Lu, P.-L., Lin, G.-H., Khine, A. A., Hu, A. & Chen, H.-P. (2016). Appl. Environ. Microbiol. 82, 6378–6385. CrossRef CAS PubMed Google Scholar
Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. Web of Science CrossRef CAS IUCr Journals Google Scholar
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A. & Wilson, K. S. (2011). Acta Cryst. D67, 235–242. Web of Science CrossRef CAS IUCr Journals Google Scholar
Yin, Y., Cao, L., Ge, H., Duanmu, W., Tan, L., Yuan, J., Tunan, C., Li, F., Hu, R., Gao, F. & Feng, H. (2017). Neuroreport, 28, 506–513. CrossRef CAS PubMed Google Scholar
Zhang, Q., Peng, H., Gao, F., Liu, Y., Cheng, H., Thompson, J. & Gao, G. F. (2009). Protein Sci. 18, 294–303. Web of Science CrossRef PubMed CAS Google Scholar
Zhong, W., Cui, Y., Yu, Q., Xie, X., Liu, Y., Wei, M., Ci, X. & Peng, L. (2014). Inflammation, 37, 1148–1157. CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.